ApprovalTrail

Approval · Notice of Compliance 15419 · 2014

LOPERAMIDE-2: Notice of Compliance 15419

Issued March 18, 2014

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
15419
Date
March 18, 2014
Company
Pro Doc LimiteeLaval, Quebec, Canada
Product type
Nonprescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Licensing agreement between two companies
Therapeutic class
Antidiarrheal

Products in this notice

BrandDINStatus today
LOPERAMIDE-202225182Marketed

Medicinal ingredients